None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Health System, Gangnam Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) or 2) with 3) 1) Non-ischemic dilated cardiomyopathy with functional class II or more and persistently reduced left ventricular ejection fraction of 35% or less than 35% even after medical treatment at least 3 months. (regardless of ICD or CRT implantation) 2) Patients with dilated cardiomyopathy who underwent ICD implantation as a secondary prevention purpose and left ventricular ejection fraction less than 50% even after medical treatment. 3) Patients with age of 19 to 85 years who agree to study enrollment.
Exclusion criteria
Exclusion criteria: 1) Patients with expected survival duration is within 6 months due to cancer or cerebrovascular disease. 2) Patients with dilated cardiomyopathy which related to neuromuscular disease 3) Patients who can't understand study purpose due to cognitive dysfunction or unstable hemodynamic status.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sudden cardiac death or admission due to heart failure aggrevation or death due to heart failure aggrevation or cardiac transplatation or left ventricular assist device implantation due to progression to end-stage heart failure | — |
Secondary
| Measure | Time frame |
|---|---|
| Appropriate anti-tachycardia pacing or appropriate ICD shock or ventricular tachycardia or ventricular fibrillation or new onset atrial fbrillation detected in EGM | — |
Countries
Korea, Republic of
Contacts
Public ContactMinjee Kim
Yonsei University Health System, Gangnam Severance Hospital
Outcome results
None listed